SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-002094
Filing Date
2019-03-15
Accepted
2019-03-15 09:01:34
Documents
83
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K osir-20181231x10k.htm 10-K 2590936
2 EX-10.1.4 osir-20181231ex1014d7a22.htm EX-10.1.4 138161
3 EX-21 osir-20181231ex210457962.htm EX-21 5082
4 EX-23.1.1 osir-20181231ex23110106f.htm EX-23.1.1 6546
5 EX-31.1.1 osir-20181231ex311100678.htm EX-31.1.1 11434
6 EX-31.2.1 osir-20181231ex31217ccea.htm EX-31.2.1 11417
7 EX-32.1.1 osir-20181231ex3211521dd.htm EX-32.1.1 9121
  Complete submission text file 0001558370-19-002094.txt   9300461

Data Files

Seq Description Document Type Size
8 EX-101.INS osir-20181231.xml EX-101.INS 1996768
9 EX-101.SCH osir-20181231.xsd EX-101.SCH 58641
10 EX-101.CAL osir-20181231_cal.xml EX-101.CAL 70643
11 EX-101.DEF osir-20181231_def.xml EX-101.DEF 181605
12 EX-101.LAB osir-20181231_lab.xml EX-101.LAB 591140
13 EX-101.PRE osir-20181231_pre.xml EX-101.PRE 408035
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32966 | Film No.: 19683142
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1